<VariationArchive VariationID="14542" VariationName="NM_000228.3(LAMB3):c.904del (p.Trp302fs)" VariationType="Deletion" Accession="VCV000014542" Version="2" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-06-10" DateCreated="2018-11-09" MostRecentSubmission="2024-06-09">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="29581" VariationID="14542">
      <GeneList>
        <Gene Symbol="LAMB3" FullName="laminin subunit beta 3" GeneID="3914" HGNC_ID="HGNC:6490" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>1q32.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="209614870" stop="209652425" display_start="209614870" display_stop="209652425" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="209788214" stop="209825819" display_start="209788214" display_stop="209825819" Strand="-" />
          </Location>
          <OMIM>150310</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_000228.3(LAMB3):c.904del (p.Trp302fs)</Name>
      <CanonicalSPDI>NC_000001.11:209630653:A:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>1q32.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="1" Accession="NC_000001.11" start="209630654" stop="209630654" display_start="209630654" display_stop="209630654" variantLength="1" positionVCF="209630653" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="1" Accession="NC_000001.10" start="209803999" stop="209803999" display_start="209803999" display_stop="209803999" variantLength="1" positionVCF="209803998" referenceAlleleVCF="CA" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>W302fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.10" sequenceAccession="NC_000001" sequenceVersion="10" change="g.209803999del" Assembly="GRCh37">
            <Expression>NC_000001.10:g.209803999del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000001.11" sequenceAccession="NC_000001" sequenceVersion="11" change="g.209630654del" Assembly="GRCh38">
            <Expression>NC_000001.11:g.209630654del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007116.1" sequenceAccession="NG_007116" sequenceVersion="1" change="g.26822del">
            <Expression>NG_007116.1:g.26822del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000228.3" sequenceAccession="NM_000228" sequenceVersion="3" change="c.904del" MANESelect="true">
            <Expression>NM_000228.3:c.904del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000219.2" sequenceAccession="NP_000219" sequenceVersion="2" change="p.Trp302fs">
            <Expression>NP_000219.2:p.Trp302fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001017402.2" sequenceAccession="NM_001017402" sequenceVersion="2" change="c.904del">
            <Expression>NM_001017402.2:c.904del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001017402.1" sequenceAccession="NP_001017402" sequenceVersion="1" change="p.Trp302fs">
            <Expression>NP_001017402.1:p.Trp302fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001127641.1" sequenceAccession="NM_001127641" sequenceVersion="1" change="c.904del">
            <Expression>NM_001127641.1:c.904del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001121113.1" sequenceAccession="NP_001121113" sequenceVersion="1" change="p.Trp302fs">
            <Expression>NP_001121113.1:p.Trp302fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA257274" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="150310.0005" DB="OMIM" />
        <XRef Type="rs" ID="786205094" DB="dbSNP" />
      </XRefList>
      <Comment DataSource="NCBI curation" Type="public">NCBI staff reviewed the sequence information reported in PubMed 9501007 Fig. 2A to determine the location of this allele on the current reference sequence.</Comment>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000228.3(LAMB3):c.904del (p.Trp302fs) AND Junctional epidermolysis bullosa, non-Herlitz type" Accession="RCV000015643" Version="25">
        <ClassifiedConditionList TraitSetID="2422">
          <ClassifiedCondition DB="MedGen" ID="C0268374">Junctional epidermolysis bullosa, non-Herlitz type</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-12-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2006-12-01" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2018-11-09" MostRecentSubmission="2024-06-09">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">17115047</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">9501007</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2422" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="5023" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1A, INTERMEDIATE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0006" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0005" DB="OMIM" />
                <XRef Type="Allelic variant" ID="150310.0001" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, DISENTIS TYPE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, NON-HERLITZ TYPE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, PROGRESSIVE</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">EPIDERMOLYSIS BULLOSA JUNCTIONALIS, SEVERE NONLETHAL</ElementValue>
                <XRef Type="MIM" ID="226650" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Epidermolysis bullosa, junctional, non-herlitz type, somatic mosaic revertant</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Adult junctional epidermolysis bullosa</ElementValue>
                <XRef ID="33662006" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Junctional epidermolysis bullosa, non-Herlitz type</ElementValue>
                <XRef ID="MONDO:0009180" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="2151" />
                <XRef ID="2151" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMB3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMC2-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="keyword">LAMA3-Related Junctional Epidermolysis Bullosa</Attribute>
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Junctional epidermolysis bullosa (JEB) is characterized by fragility of the skin and mucous membranes, manifest by blistering with little or no trauma. Blistering may be severe and granulation tissue can form on the skin around the oral and nasal cavities, fingers and toes, and internally around the upper airway. Blisters generally heal with no significant scarring. Broad classification of JEB includes JEB generalized severe and JEB generalized intermediate. In JEB generalized severe, blisters are present at birth or become apparent in the neonatal period. Congenital malformations of the urinary tract and bladder may also occur. In JEB generalized intermediate, the phenotype may be mild with blistering localized to hands, feet, knees, and elbows with or without renal or ureteral involvement. Some individuals never blister after the newborn period. Additional features shared by JEB and the other major forms of epidermolysis bullosa (EB) include congenital localized absence of skin (aplasia cutis congenita), milia, nail dystrophy, scarring alopecia, hypotrichosis, pseudosyndactyly, and other contractures.</Attribute>
                <XRef ID="NBK1125" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301304</ID>
                <ID Source="BookShelf">NBK1125</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301481</ID>
                <ID Source="BookShelf">NBK1304</ID>
              </Citation>
              <XRef ID="251393" DB="Orphanet" />
              <XRef ID="79402" DB="Orphanet" />
              <XRef ID="79405" DB="Orphanet" />
              <XRef ID="89840" DB="Orphanet" />
              <XRef ID="C0268374" DB="MedGen" />
              <XRef ID="MONDO:0009180" DB="MONDO" />
              <XRef Type="MIM" ID="226650" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="35908" SubmissionDate="2018-11-07" DateLastUpdated="2024-06-09" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="150310.0005_EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1A, INTERMEDIATE" title="LAMB3, 1-BP DEL, 904T_EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1A, INTERMEDIATE" />
        <ClinVarAccession Accession="SCV000035908" DateUpdated="2024-06-09" DateCreated="2013-04-04" Type="SCV" Version="5" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-12-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">Posteraro et al. (1998) described a patient with a nonlethal variant of junctional epidermolysis bullosa (JEB1A; 226650) who was found to be compound heterozygous for mutations affecting the LAMB3 gene. From his father he had inherited a deletion of a single base (904delT) leading to frameshift and a premature termination codon, which resulted in mRNA decay. From his mother he had inherited a G-to-A transition at the last base of exon 7 (628G-A), resulting in a glu210-to-lys (E210K) substitution (150310.0006). The 628G-A mutation altered the correct splicing of LAMB3 pre-mRNA giving rise to 2 aberrant mRNAs, in addition to the RNA transcripts carrying the G-to-A substitution. The findings were considered compatible with the reduced expression of mutated laminin-5 molecules with altered biologic activity, and the mild junctional EB phenotype observed in the patient. Mavilio et al. (2006) transduced epidermal cells from this patient with a retroviral vector expressing LAMB3 and successfully transplanted 9 genetically corrected cultured epidermal skin grafts onto the anterior upper regions of the patient's legs. Retroviral integration site analysis indicated that the regenerated epidermis was maintained by a defined repertoire of transduced stem cells.</Attribute>
              <Citation>
                <ID Source="PubMed">9501007</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">17115047</ID>
              </Citation>
              <XRef DB="OMIM" ID="226650" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="LAMB3" />
          </GeneList>
          <Name>LAMB3, 1-BP DEL, 904T</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 904T</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="150310.0005" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1A, INTERMEDIATE</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="35908" TraitType="Disease" MappingType="Name" MappingValue="EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1A, INTERMEDIATE" MappingRef="Preferred">
        <MedGen CUI="C0268374" Name="Junctional epidermolysis bullosa, non-Herlitz type" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

